Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01785342 · ClinicalTrials.gov registry record
DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules
A clinical trial of Lung Cancer, sponsored by Boston University.
- Completed
- Registry status
- 489
- Enrollment target
- 15
- Study locations
NCT01785342: Completed study of Lung Cancer, sponsored by Boston University.
NCT01785342 is a study of Lung Cancer that has completed, run by Boston University. The registered enrollment target is 489 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (48% lower). The trial reports 15 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01785342, a study of Lung Cancer, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- 489 participants
- Enrollment target
- 15
- Study locations
Study Summary
The goal is to improve the efficiency of the diagnostic follow-up of patients with indeterminate pulmonary nodules by determining whether biomarkers for lung cancer diagnosis that are measured in minimally invasive biospecimens are able to distinguish malignant from benign pulmonary nodules that are incidentally detected in high-risk smokers.
Primary Outcome
Subjects will be identified as Lung Cancer or no Lung Cancer (through diagnosis) within the 2 year followup period.
Conditions Studied
Interventions
- OTHER Biosample and Imaging Collection
Study Locations (15)
California
- Regents of the University of California LA (Los Angeles VA Healthcare System) - Los Angeles
- University of California Los Angeles Medical Center - Los Angeles
- Naval Medical Center San Diego - San Diego
Pennsylvania
- Trustees of University of Pennsylvania (Philadelphia VA Medical Center) - Philadelphia
- University of Pennsylvania - Philadelphia
- Veterans Research Foundation of Pittsburgh - Pittsburgh
Massachusetts
- Boston University Medical Center - Boston
- Boston VA Research Institute, Inc - Boston
Texas
- Dallas VA Research Corporation - Dallas
- San Antonio Military Medical Center - San Antonio
Colorado
- Denver Research Institute - Denver
Maryland
- Walter Reed National Military Medical Center - Bethesda
New York
- Health Research Inc. Roswell Park Division - Buffalo
Tennessee
- Middle Tennessee Research Institute (Vanderbilt University) - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 489 participants |
| Start Date | 2013-01 |
| Est. Completion | 2022-02-28 |
What the finished NCT01785342 record still lists
NCT01785342 is an observational study that tracks outcomes without assigning an intervention. The registered 489 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Biosample and Imaging Collection is the first listed.
NCT01785342 lists 15 locations in 9 states (California, Pennsylvania, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT01785342 about?
NCT01785342 is a clinical study titled "DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules". The goal is to improve the efficiency of the diagnostic follow-up of patients with indeterminate pulmonary nodules by determining whether biomarkers for lung cancer diagnosis that are measured in minimally invasive biospecimens are able to distinguish malignant from benign pulmonary nodules that are...
What is the current status of trial NCT01785342?
This trial is currently completed. The enrollment target is 489 participants. The study started on 2013-01. Estimated completion is 2022-02-28.
What conditions does trial NCT01785342 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT01785342?
The interventions under investigation include: Biosample and Imaging Collection (OTHER).
Who is sponsoring clinical trial NCT01785342?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01785342 being conducted?
This trial has 15 study locations across California, Colorado, Maryland, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01785342's enrollment target sits among peer trials
489 74th of 409 higher than 336 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04728893 · 490 participants · Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- NCT06238479 · 490 participants · Phase 1
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- NCT06336928 · 490 participants
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
- NCT06641414 · 490 participants · Phase 3
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia